isoxazoles has been researched along with Adenomatous Polyposis Coli, Familial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cacheux, W; Chaussade, S; de Reyniès, A; Hamzaoui, N; Lamarque, D; Perret, C; Romagnolo, B; Terris, B; Zagani, R | 1 |
| FitzGerald, GA | 1 |
2 other study(ies) available for isoxazoles and Adenomatous Polyposis Coli, Familial
| Article | Year |
|---|---|
Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Topics: Adenomatous Polyposis Coli; Animals; Antineoplastic Agents; beta Catenin; Cell Line, Tumor; Cell Survival; Colonic Polyps; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase Inhibitors; DNA-Binding Proteins; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, APC; Humans; Isoxazoles; Lactones; Mice; Mice, Mutant Strains; Nuclear Receptor Subfamily 4, Group A, Member 2; Oligonucleotide Array Sequence Analysis; Osteopontin; Promoter Regions, Genetic; RNA Interference; Signal Transduction; Sulfones; Time Factors; Transcription Factors; Transfection; Wnt Proteins | 2009 |
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approach.
Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular System; Celecoxib; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Isoxazoles; Lactones; Male; Pyrazoles; Sulfonamides; Sulfones | 2002 |